- cafead   Feb 03, 2023 at 11:12: AM
via MaaT Pharma’s 18-month struggle to get out from under an FDA clinical hold may be entering its endgame. In its latest feedback, the agency reportedly agreed to a list of conditions that could enable clinical evaluation of the company's pooled fecal therapy MaaT013 in the U.S.
article source
article source